InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong · Delayed Price · Currency is HKD 60.10
+4.70 (8.48%)
Sep 30, 2026, 4:08 PM HKT
HKG:3696 Market Cap
HKG:3696 has a market cap or net worth of 31.9 billion as of September 29, 2026.
Market Cap
31.90B
Enterprise Value
27.47B
Revenue
1.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
60.10
ChartMarket Cap Chart
Since December 30, 2025, HKG:3696's market cap has increased from 16.66B to 31.90B, an increase of 91.46%. That is a compound annual growth rate of 138.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 31.90B | 54.55% |
| Dec 31, 2025 | 20.64B | 23.88% |
| Dec 30, 2025 | 16.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akeso | 86.17B |
| RemeGen | 63.22B |
| Biocytogen Pharmaceuticals (Beijing) | 57.27B |
| 3SBio | 39.83B |
| Shanghai Junshi Biosciences | 35.97B |
| Shanghai Henlius Biotech | 31.19B |
| InnoCare Pharma | 29.94B |
| Keymed Biosciences | 22.08B |